Navigation Links
New pyrimidine compounds may lead to improved treatments for childhood brain cancer
Date:4/6/2010

April 6, 2010 (Philadelphia, PA) -- Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

A recent study shows that pyrazolo-[3,4-d]pyrimidine-derivatives, designed to target Src, may be effective in interfering with the cell cycle and causing cancer cell death in medulloblastoma. The results were published in FASEB (The Journal of the Federation of American Societies for Experimental Biology) and were funded by the Sbarro Health Research Organization Center for Biotechnology (www.shro.org), a nonprofit group devoted to molecular and genetic research located at the College of Science and Technology at Temple University in Philadelphia, PA and the Human Health Foundation (www.hhfonlus.org), a nonprofit biotechnology research organization located in Terni, Italy.

"Our aim was to investigate the inhibitory effects of new pyrimidine-derivatives," said lead author Antonio Giordano, M.D. PhD, the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine and a 'Chiara fama' Professor at the Department of Human Pathology and Oncology, University of Siena, Siena, Italy. "Our findings show that, in medulloblastoma cells, pyrimidine derivatives can downregulate Src activity and reduce cell proliferation and tumor progression in vivo. This suggests that pyrimidine derivatives could be an effective therapeutic strategy not only for the treatment of medulloblastomas, but also for other Src expressing tumors."

Although better treatment regimens, including surgery, chemotherapy and radiotherapy have substantially improved survival, medulloblastoma remains incurable in about one third of patients and current treatments can cause toxic neurocognitive side effects.

"Compared
'/>"/>

Contact: Ilene Rush
irush@shro.org
215-470-2998
Sbarro Health Research Organization
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
2. Compounds Identified That Might Treat Nerve Diseases
3. Prenatal exposure to flame-retardant compounds affects neurodevelopment of young children
4. Marijuana Compounds Could Beat Back Brain Cancer
5. Spice Compounds May Stem Tumor Growth
6. Foster care associated with improved growth, intelligence compared to orphanage care
7. Improved device provides more rapid, comprehensive analysis of circulating tumor cells
8. Improved patient care with telemonitoring
9. Improved doctor-pharmacist collaboration needed: study
10. An improved method for calculating tumor growth
11. TeraMedica Unveils Improved Univision, Now Offering a Multi-Layer Enterprise Viewing Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Daily Gossip reporters have subjected Joel Marion and Brett ... Fat to a close analysis with the intention to ... is a detailed explanation of the diet suggested by ... two nutritionists have discovered during their research that there is ... and expenditure of our body, that is, the leptin hormone. ...
(Date:5/19/2013)... Reporter , , SATURDAY, May 18 (HealthDay News) -- ... disease overcome the fatigue and decreased muscle strength ... new research. Extra vitamin D "was associated ... greater quality of life and the ability to ... a research dietitian and doctoral candidate at Trinity ...
(Date:5/19/2013)... May 19, 2013 People in Minnesota have ... Altman Fitness is offering its 28 Day Fat Loss Formula. ... from the comfort of their own home. The product sells ... More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , ... leave their houses now, but after using the 28 Day ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob Poulos ... with fat burning diet plans, training workouts, ... Furnace package, people will receive the Fat Burning Furnace ... The Fat Burning Furnace manual includes fat loss knowledge, ... mass. In addition, this book covers step-by-step instructions, techniques ...
Breaking Medicine News(10 mins):Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... HealthDay Reporter , MONDAY, Feb. 28 (HealthDay News) -- Instructions ... sometimes taking an average of seven pills a day, may ... many patients don,t realize that they can take several medications ... easy to grasp are sorely needed, the researchers added. ...
... the failure of enzymes to break down specific kinds of ... severe physical and neurological problems and sometimes early death. ... of the Journal of Biological Chemistry , researchers at ... by Jeffrey D. Esko, PhD, professor in the Department of ...
... Researchers at the Cummings School of Veterinary Medicine have received ... Syndrome (HUS), a potentially fatal outcome of E. coli ... children. HUS is caused by the forms of ... for about 100,000 annual cases of illness in the United ...
... WASHINGTON, February 28, 2011) Results from a study ... American Society of Hematology reveal a close relationship between ... arteries carrying blood from the heart to the lungsand ... (known as myeloid abnormalities). The study, which was ...
... , MONDAY, Feb. 28 (HealthDay News) -- A ... of depression are less likely than other heart attack patients ... analyzed data on 6,874 heart attack patients admitted to 96 ... March 2005. Of these patients, 680 had a history of ...
... Kansas State University chemistry professor has been selected as ... promising young scholar, particularly in the research areas of ... professor of chemistry, has received the two-year $50,000 award, ... early-career scientists and scholars as a way to recognize ...
Cached Medicine News:Health News:Confusion Over Drug Dosing Common for Seniors 2Health News:Confusion Over Drug Dosing Common for Seniors 3Health News:New marker found for Sanfilippo disease 2Health News:Tufts receives patent for antibody treatment against hemolytic uremic syndrome 2Health News:Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities 2Health News:Heart Patients With Depression Often Find ER Delays 2Health News:K-State chemist's work brings more national recognition as promising early-career scientist 2
(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... , , , Letters ... , DES PLAINES, Ill., Sept. 10 The American Brain Tumor ... and creative research ideas for solving the challenges of brain tumor diagnosis and ... scientific breakthroughs over the past decade resulting in better treatments and longer lives ...
... EMERYVILLE, Calif., Sept. 10 NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: ... clinical stage company developing novel anti-infective compounds for the treatment ... fungal infections, announced today the start of a Phase 2a ... , , NovaBay,s partner in ...
Cached Medicine Technology:American Brain Tumor Association Calls for Discovery Research 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 3NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 4
... The OSOM Ultra Strep A Test is ... Technology (DLT)**. DLT uses antibody labeled color ... the test device. DLT allows greater sensitivity ... sacrificing specificity. In the test procedure, a ...
... The female Fertell test is an easy ... that measures ovarian reserve by means of determining ... an in-stream urine sample. The test is performed ... 3 of the menstrual cycle) and is similar ...
... The Cholestech GDX System delivers an unmatched ... the ideal solution for assessing and monitoring a ... product demo, click here ., ,The CLIA-waived ... delivers A1C results in less than 5 minutes. ...
... using patented, innovative technology, measures a complete ... only 5 minutes from a simple fingerstick. ... get immediate liver function results. The scope ... only advantage to healthcare providers. The physician, ...
Medicine Products: